10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,015 | +320.6% | 107,718 | +174.4% | 0.05% | +133.3% |
| Q4 2022 | $1,430 | -99.9% | 39,250 | +100.6% | 0.02% | +10.5% |
| Q1 2022 | $1,488,000 | +116.3% | 19,563 | +323.3% | 0.02% | +171.4% |
| Q4 2021 | $688,000 | -35.7% | 4,621 | -15.5% | 0.01% | -41.7% |
| Q2 2021 | $1,070,000 | -66.1% | 5,466 | -75.5% | 0.01% | -61.3% |
| Q4 2020 | $3,161,000 | -52.7% | 22,326 | -58.3% | 0.03% | -76.7% |
| Q3 2020 | $6,680,000 | – | 53,581 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |